Engineers Gate Manager LP Ionis Pharmaceuticals Inc Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 78,874 shares of IONS stock, worth $2.81 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

78,874

Previous 16,320 383.3%

Holding current value

$2.81 Million

Previous $777,000 306.56%

% of portfolio

0.06%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.06 - $51.86 $2.51 Million - $3.24 Million	62,554 Added 383.3%	78,874 $3.16 Million
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $811,814 - $1.06 Million	-22,272 Reduced 57.71%	16,320 $777,000
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $408,321 - $520,238	9,715 Added 33.64%	38,592 $1.67 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $1.25 Million - $1.49 Million	28,877 New	28,877 $1.46 Million
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $10,175 - $12,695	-293 Reduced 0.85%	34,047 $1.4 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $482,309 - $591,755	14,363 Added 71.9%	34,340 $1.23 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $500,526 - $627,275	13,484 Added 207.67%	19,977 $754,000
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $373,073 - $496,818	-10,210 Reduced 61.13%	6,493 $287,000
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $216,737 - $293,905	6,835 Added 69.26%	16,703 $618,000
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $732,418 - $907,924	-24,512 Reduced 71.3%	9,868 $366,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $453,501 - $621,550	17,708 Added 106.21%	34,380 $1.05 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $559,178 - $676,049	16,672 New	16,672 $559,000
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $1.01 Million - $1.38 Million	-29,160 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $936,920 - $1.41 Million	22,040 Added 309.55%	29,160 $1.31 Million
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $323,306 - $430,146	-7,137 Reduced 50.06%	7,120 $403,000
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $676,494 - $897,478	14,257 New	14,257 $676,000
Q2 2020 Aug 17, 2020	SELL	$46.85 - $61.05 $355,966 - $463,857	-7,598 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $255,964 - $390,100	-6,153 Reduced 44.75%	7,598 $359,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $740,491 - $897,527	13,751 New	13,751 $831,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $1.69 Million - $2.34 Million	-27,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $1.44 Million - $2.21 Million	27,200 New	27,200 $2.21 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.06B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Ionis Pharmaceuticals Inc Transaction History